Herbs (Global Traditional) · Amazonian
Cordoncillo Negro (Piper aduncum) (Piper aduncum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Cordoncillo negro (Piper aduncum) is an Amazonian plant containing dillapiol, linalool, and nerolidol compounds that demonstrate antifungal and antimicrobial properties. Laboratory studies show activity against skin pathogens and various bacterial strains, though clinical evidence remains limited.
Cordoncillo Negro (Piper aduncum) is a shrub native to tropical rainforests of Central and South America, including Peru, Mexico, and the Caribbean. The medicinal parts are primarily the leaves and bark, harvested fresh or dried, and prepared as infusions, decoctions, tinctures, or essential oils obtained via steam distillation.
No human clinical trials, RCTs, or meta-analyses have been conducted on Cordoncillo Negro. Evidence is limited to in vitro studies demonstrating antimicrobial, antifungal, and cytotoxic effects on cancer cells and bacteria in laboratory settings.
Traditional herbal literature recommends infusions of 1g herb per cup, 2-3 times daily, or 10% infusion 3-4 times daily. No clinically studied dosages are available due to lack of human trials. Consult a healthcare provider before starting any new supplement.
Piper aduncum is not consumed as a food staple and therefore lacks a conventional macronutrient profile (calories, protein, fat, carbohydrates, fiber are not meaningfully characterized in dietary terms). Its relevance is almost entirely phytochemical/bioactive. Key bioactive compounds identified in essential oil and leaf extracts include: • **Dillapiol** (phenylpropanoid) — dominant constituent of the essential oil, often comprising 40–90% of total oil depending on chemotype and geographic origin; reported concentrations in Amazonian specimens frequently range from 60–85% of essential oil content. Exhibits antifungal and synergistic insecticidal activity. • **1,8-Cineole (eucalyptol)** — typically 2–10% of essential oil; contributes to antimicrobial and mild bronchodilatory properties. • **Piperitone** — variable, reported at 1–8% in some chemotypes. • **Linalool** (monoterpene alcohol) — typically 0.5–5% of essential oil; mild antimicrobial and anxiolytic properties. • **trans-Nerolidol** (sesquiterpene alcohol) — reported at 1–7%; antifungal and antiparasitic activity noted in vitro. • **β-Caryophyllene** (sesquiterpene) — approximately 1–6% of essential oil; anti-inflammatory via CB2 receptor agonism. • **Myristicin** — trace to minor amounts (~0.5–3%); structurally related to dillapiol. • **Flavonoids** — including 2',6'-dihydroxy-4'-methoxychalcone and other chalcones isolated from leaves; concentrations not precisely quantified in bulk tissue but detected in methanol/ethanol extracts. These exhibit antioxidant and anti-inflammatory activity. • **Chromenes** (e.g., methyl-2,2-dimethyl-2H-chromene-6-carboxylate)** — minor constituents with reported bioactivity. • **Tannins and phenolic acids** — present in aqueous and ethanolic leaf extracts; total phenolic content reported at approximately 30–80 mg gallic acid equivalents (GAE) per gram of dry extract, depending on extraction method. • **Saponins** — detected qualitatively in leaf extracts. **Mineral content** of dried leaves (limited data): potassium, calcium, magnesium, and iron are present in trace amounts consistent with tropical herbaceous plants, but precise quantification specific to P. aduncum is sparse in the literature. **Vitamins**: No reliable data on vitamin content. **Bioavailability notes**: Dillapiol and other phenylpropanoids are lipophilic and moderately absorbed through gastrointestinal mucosa when consumed as teas or decoctions, though first-pass hepatic metabolism is significant. Essential oil constituents are volatile and partially lost during traditional boiling preparations. Flavonoid bioavailability is generally low (estimated <5–10% oral absorption) without lipid co-administration. Topical application of essential oil allows direct dermal absorption of dillapiol and terpenes, which is the more relevant route for antifungal use. Dillapiol is also a known inhibitor of cytochrome P450 enzymes, which may alter metabolism of co-administered substances.
Cordoncillo negro's bioactive compounds, particularly dillapiol, linalool, and nerolidol, disrupt fungal cell membrane integrity and bacterial cell wall synthesis. These essential oil components interfere with ergosterol biosynthesis in fungi and peptidoglycan formation in bacteria. The antimicrobial activity appears to involve multiple cellular targets, making resistance development less likely.
Current evidence for cordoncillo negro consists primarily of in vitro laboratory studies demonstrating antifungal activity against dermatophyte species and antimicrobial effects against gram-positive and gram-negative bacteria. No randomized controlled trials in humans have been published to date. Traditional use documentation exists for digestive complaints and topical applications, but lacks quantified clinical outcomes. The strength of evidence remains preliminary and requires human clinical validation.
Safety data for cordoncillo negro supplementation is limited, with no established safe dosage ranges or comprehensive toxicity studies. Essential oil components like dillapiol may cause skin sensitization or allergic reactions in susceptible individuals. Potential interactions with antifungal medications or antibiotics are unknown due to lack of pharmacokinetic studies. Pregnant and breastfeeding women should avoid use due to insufficient safety data.
